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Abstract
Aims: To investigate the association between the presence and characteristics of uterine leiomyomata (UL) and
self-reported stress urinary incontinence (SUI).
Methods: The study included 836 premenopausal participants (474 African American and 362 Caucasian) in the
National Institute of Environmental Health Sciences (NIEHS) Uterine Fibroid Study. UL were characterized at
baseline with ultrasound screening, and SUI was assessed at follow-up (after 4 years, on average). Linear risk
models were used to estimate adjusted prevalence differences (aPD) and 95% confidence intervals (CI), con-
trolling for age, ethnicity, body mass index (BMI), and number of deliveries.
Results: Compared with women without UL, SUI prevalence was higher among women with any UL
(aPD¼ 7.4%, 95% CI 0.4-14.3) and women with UL 2–4 cm (aPD¼ 9.6%, 95% CI 1.3-17.9). Marginally significant
results were found for the presence of UL 4 cm and anterior UL 2 cm.
Conclusions: The observed 7% increase in prevalence of this common condition for women with UL is of clinical
importance. Further research is needed before concluding that treatment for larger UL might enhance SUI
treatment in some women.
Introduction
Urinary incontinence is one of the most common typesof lower urinary tract dysfunction, affecting about a
third of adult women in the United States.1 The total cost of
urinary incontinence in the United States was estimated to be
$19.5 billion (in 2000 dollars).2 Stress urinary incontinence
(SUI), the complaint of involuntary leakage of urine on effort
or exertion or on sneezing or coughing,3 is the most common
type of urinary incontinence in women4 and can have a sub-
stantial negative impact on quality of life.5 Established risk
factors for self-reported SUI symptoms include older age,6
Caucasian vs. African American ethnicity,7,8 high body mass
index (BMI),7,9 and parity,10 especially vaginal deliveries.11,12
Uterine enlargement due to the presence of uterine leio-
myomata (UL), in particular large UL in the anterior lower
uterus, has been hypothesized to cause SUI by compressing
the urinary bladder.13 In particular, laughing, coughing, or
sneezing may displace UL against the bladder and cause in-
voluntary loss of urine (i.e., SUI). There is a case report of a
pedunculated UL causing acute SUI.14 Although it has been
hypothesized that UL may be associated with SUI,13,15,16 to
our knowledge, only one population-based observational
study has directly tested this hypothesis, and it found no as-
sociation between self-reported UL and prevalent SUI.17
Therefore, the objective of this study was to investigate the
association between SUI and UL, considering not only the
presence of UL but also their characteristics. We examined
this relationship in 474 African American and 362 Caucasian
premenopausal women who participated in the first follow-
up interview of the National Institute of Environmental
Health Science’s (NIEHS) Uterine Fibroid Study (UFS).
Materials and Methods
The NIEHS UFS was designed to measure the prevalence of
UL, identify risk factors for UL, identify biological changes in
tumor tissue compared with normal uterine muscle, and de-
scribe women’s experience of symptoms associated with UL
and how they change over time among African American and
Caucasian women, aged 35–49. The study was approved by
Human Subject Review Boards at the NIEHS and George
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Washington University. Enrollment occurred between 1996
and 1999, at which time participants were screened for UL by
ultrasound and asked to provide baseline data by telephone
interview and mail questionnaire. Premenopausal partici-
pants were followed up in 2001–2002 using a computer-
assisted telephone interview. Details of the study have been
published.18
Study participants
The UFS enrolled women aged 35–49 years selected ran-
domly from a computerized list of health plan members at
a Washington, DC, site. In addition to age and health plan
membership requirements, eligible women had to be able to
complete the UFS study interview in English. Of the 2102
women screened for enrollment, 316 (15%) were ineligible,
primarily because they did not obtain care at the Washington,
DC, health plan site. Of the 1786 eligible women, 335 (19%)
refused to participate, and 21 (1%) were lost to contact prior
to data collection. In total, 1430 women, constituting 80%
of the eligible women, participated in the baseline phase of
the UFS.
Premenopausal participants were eligible for follow-up.
Among the 1430 baseline participants, 1142 were premeno-
pausal African American or Caucasian women, and of these,
911 participated in the first follow-up of the NIEHS UFS.
Of the 231 women who did not complete the follow-up, 107
(46%) refused to participate, 121 (52%) were unable to be
contacted, and 3 (1%) were deceased. Compared with the 911
women who participated in the follow-up, the 231 women
who did not complete the follow-up were more likely to
have UL, to be African American, to be younger, and to have
a higher BMI on average. Women were excluded from the
current study if they were missing data on SUI at follow-up
(n¼ 4) or UL status at baseline (n¼ 57). In addition, women
were excluded if they were pregnant during the 12 months
before follow-up, the time interval for which they reported
SUI (n¼ 14). The final population included 836 premeno-
pausal women, 474 African American and 362 Caucasian.
Compared with the 836 women included in the study, the
75 women excluded from the study were similar with respect
to race and were younger and had a lower BMI on average.
Determination of UL status
UL status was based on ultrasound evidence of fibroids.
For 76% of the women, UL was identified or confirmed based
on an ultrasound screening examination conducted for the
study at the primary care site at baseline. The other women,
who either had UL documented in a sonogram within the
previous 5 years or were negative for UL based on a sonogram
within the previous 2 years, were classified according to their
previous sonogram.
Study ultrasound examinations included both transab-
dominal and transvaginal examinations to facilitate identifi-
cation of UL in the upper uterus. Both examinations were
performed by sonographers certified by the American Reg-
istry of Diagnostic Medical Sonographers, under the super-
vision of a radiologist with fellowship training in sonography.
A single radiologist reviewed all questionable sonograms.
Sonographers filled out a study-specific data collection form
that included data on uterine size, uterine shape, the presence
of diffuse heterogeneous echo pattern, number of focal UL,
the size and location of the two largest UL (if at least 2 cm in
diameter), and the size of the three largest submucosal UL.
UL status was classified according to (1) UL presence (no,
yes), (2) UL size (no UL; 2 cm, small UL; 2–4 cm, medium
UL;4 cm, large UL), (3) the presence of an anterior UL4 cm
(large) in a nonretroverted uterus (no UL, yes, other UL), or
(4) the presence of an anterior UL 2 cm (medium=large) in a
nonretroverted uterus (no UL, yes, other UL). In addition,
each woman’s uterine size was classified as small (91.4 cm3,
the lowest third of the overall uterine volume distribution),
medium (>91.4 cm3 but 148.9 cm3, the middle third), large
(>148.9 cm3 but 213.0 cm3, the 67th to 83rd percentile), and
very large (>213.0 cm3, or above the 83rd percentile). Uterine
volume was calculated using the prolate ellipsoid formula
(0.52lengthwidthanterior=posterior diameter).
The ‘‘no UL’’ reference category included women who had
neither focal UL nor a diffuse heterogeneous echo pattern
present. The latter may result from multiple small focal UL or
from larger UL that lack the usual distinct histological de-
marcation from the surrounding myometrium. We consid-
ered the diffuse heterogeneous echo pattern to be an indicator
of UL because, like focal UL, this pattern was associated
with uterine enlargement18 and excess bleeding.19 For the
89 women who had a diffuse heterogeneous echo pattern and
no detectable focal UL, we assigned a UL size based on their
uterine volume (calculated based on a regression model pre-
dicting size of largest fibroid from uterine size for all partici-
pants with both measurements). Sensitivity analyses were
conducted with and without this group of women.
SUI determination
Data collected at the follow-up (2001–2002) during a
computer-assisted telephone interview included self-reported
SUI, which was classified as positive if women reported that
they ever had urine leak when they coughed or sneezed
during the 12-month interval before their follow-up reference
date. The reference date for women who had UL treated by
myomectomy, hystereoscopic resection, uterine artery embo-
lization, or hysterectomy was the date of the procedure or
the date of their last menstrual period, whichever came first.
The reference date for women who did not undergo any of the
procedures listed was the date of their follow-up interview if
they had a recent menstruation or the date of their last period
if they did not report a period in the last 2 months.
Data analysis
Potential confounders were selected by reviewing the lit-
erature on UL and SUI. They were age at the reference date
(continuous or categorized as <40, 40–44, 45–49, 50), eth-
nicity (African American, Caucasian), BMI at baseline (kg=m2,
categorized as <25, 25–29, 30–34, 35), and the number of
deliveries prior to the reference date (categorical, 0, 1, 2, 3).
A composite variable involving the number and the type of
deliveries (none, only cesarean section deliveries, 1 vaginal
delivery, 2 vaginal deliveries, 3 vaginal deliveries) was also
evaluated as a potential confounder but was not used because
results were comparable with those adjusted for the number
of deliveries. A history of vaginal deliveries variable (no de-
liveries or only cesarean section deliveries, 1 or more vaginal
deliveries) was also created to be evaluated as a potential
effect modifier.
246 DRAGOMIR ET AL.
Univariate analyses were performed to describe distribu-
tions of exposures and outcomes and to assess missing data.
We used linear risk models to estimate prevalence differences
(PD) and corresponding 95% confidence intervals (CI),20 with
separate linear risk models used to evaluate the association
between each of the five UL variables of interest and self-
reported SUI. We estimated crude and adjusted PD (aPD) and
95% CIs, which are reported as percent prevalence differ-
ences. As it was decided a priori to include all the potential
confounders in the final models, the adjusted estimates were
based on models that included age at reference (continuous),
ethnicity, BMI at baseline, and number of deliveries. All
model estimates were evaluated to confirm that predicted
prevalences were between 0 and 1.
In secondary analyses, we explored the roles of ethnicity,
parity, history of vaginal deliveries, and BMI as potential
effect modifiers. Ethnicity (African American or Caucasian)
was evaluated based on reported evidence consistent with
ethnic differences in the association between UL and urinary
incontinence.17 We evaluated effect modification by parity
(nulliparous vs. parous) because pregnancy may increase
susceptibility to SUI because of its effects on the pelvic floor.
History of vaginal deliveries may act as an effect modifier if
the presence of UL accelerates the development of SUI initi-
ated by vaginal deliveries. BMI was investigated as a poten-
tial effect modifier, as the effect of a large UL may be different
for obese and nonobese women. The evaluations of effect
modification (specifically, risk difference modification) by
ethnicity, parity, history of vaginal deliveries, and BMI were
performed using likelihood ratio tests for corresponding in-
teractions (a¼ 0.10). All analyses were performed using the
SAS software package (Cary, NC).
Results
Over half of study participants were African American, and
a third were nulliparous. Most women were aged 40–49 on
the reference date (mean SD, 45.8 3.9 years), and 60%
were overweight or obese (mean BMI SD, 28.6 7.6 km=m2).
The average time from the ultrasound examination to the
reference date was about 4 years (mean SD, 3.9 2.0 years),
and the average time from the reference date to the follow-up
was 0.66 years (mean SD, 0.66 1.3 years). The reference
date preceded the follow-up date for 269 (32%) women: for 75
(9%) women because of treatment for UL and for 194 (23%)
women because of reaching the menopause.
Overall, 414 of 836 (49.5%) study participants reported SUI
during the reference period. African American women re-
ported less SUI than Caucasian women (43% vs. 58%), and
there was a general tendency for the prevalence of SUI to
increase with age. Caucasian ethnicity, BMI at baseline, and
number of deliveries were positively associated with SUI
(Table 1). Sixty-four percent of participants had at least one
UL (534 of 836), and the prevalence of SUI was 51% among
women with UL compared with 46% among women without
UL. The crude and adjusted prevalence differences and their
95% CIs for SUI in association with UL were PD¼ 5.0, 95%
CI 2.1-12.0, and aPD¼ 7.4 95%, CI 0.4-14.3, respectively
(Table 2 and Fig. 1).
The prevalence of SUI was similar for women with no UL
and for those with UL<2cm but was statistically significantly
increased among women with UL 2–4 cm (aPD¼ 9.6, 95%
CI 1.3-17.9) and marginally significantly increased among
women with UL4 cm (aPD¼ 9.3, 95% CI0.4-18.9) (Table 2
and Fig. 1). Contrary to expectations, the association bet-
ween UL and SUI was not stronger for large (4 cm) anterior
UL in a nonretroverted uterus (aPD¼ 4.3, 95% CI 11.9-20.6)
than for other UL (aPD¼ 7.4, 95% CI 0.2-14.4); however,
estimates were imprecise because of the small number of
observations in the former group. The association between
the presence of anterior UL 2 cm in a nonretroverted uterus
and SUI (aPD¼ 9.8, 95% CI 0.3-19.7) was marginally sig-
nificant and somewhat larger than the association estimated
for other UL and SUI (aPD¼ 6.2, 95% CI 1.3-13.7).
Table 1. Study Population Characteristics at Baseline and Stress Urinary Incontinence
at Follow-up among 836 Premenopausal Women, NIEHS Uterine Fibroid Study
Characteristic
Total SUI Crude
n % n % PD (%) 95% CI
Age at reference date
<40 58 6.9 25 43.1 0
40–44 294 35.2 136 46.3 3.2 10.9-16.7
45–49 339 40.6 172 50.7 7.6 6.3-21.0
50 145 17.3 81 55.9 12.8 2.4-27.5
Ethnicity
African American 474 56.7 205 43.3 0
Caucasian 362 43.3 209 57.7 14.5 7.7-21.2
BMI at baseline (kg=m2)
<25 337 40.3 145 43.0 0
25–29 221 26.4 117 52.9 9.9 1.5-18.3
30–34 126 15.1 64 50.8 7.8 2.4-17.9
35 152 18.2 88 57.9 14.9 5.3-24.2
Number of deliveries
0 304 36.4 136 44.7 0
1 147 17.6 74 50.3 5.6 4.2-15.4
2 254 30.4 136 53.5 8.8 0.5-17.1
3 131 15.7 68 51.9 7.2 3.1-17.3
SUI, stress urinary incontinence; PD, prevalence differences; CI, confidence interval.
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After adjustment for the potential confounders, the preva-
lence of SUI among women with a very large uterine volume
(>213 cm3) was increased relative to women with a small
uterine volume (91.4 cm3) (aPD¼ 8.7, 95% CI 1.9-19.0),
although the result was not statistically significant.
There was no evidence that the associations between UL or
uterine size and SUI differed by race, parity, history of vaginal
deliveries, or BMI (all p values for interactions from linear risk
models>0.10). For example, race-specific associations between
UL presence and SUI were aPD¼ 8.5, 95% CI 1.0-18.1 for
African Americans and aPD¼ 6.3, 95% CI 3.8-16.3 for Cau-
casians ( p value for test for interaction between ethnicity and
UL presence 0.75). As the study did not have enough statistical
power to detect effect modification, these results should be
considered exploratory and interpreted with caution.
The results were not substantially different when the 89
women who had a diffuse heterogeneous echo pattern and no
detectable focal UL were excluded. For example, after this
exclusion, the adjusted PD and the 95% CI for the association
between UL with SUI was aPD¼ 7.9, 95% CI 0.5-15.1. It is
important to note that exclusion of the 125 women who had
their reference date preceding the follow-up by 2 years or more
did not substantially alter the results. For example, after their
exclusion, the adjusted PD and the 95% CI for the association
between UL with SUI were aPD¼ 7.6, 95% CI 0.2-15.1.
Discussion and Conclusions
Although several articles have hypothesized that UL may
influence SUI,15,16 to our knowledge, this is only the second
epidemiological study to systematically evaluate the associ-
ation between UL and self-reported SUI. In addition to the
presence or absence of any UL, we evaluated the size of
the largest UL, UL location, and overall uterine volume be-
cause these characteristics may affect SUI by increasing
pressure exerted on the bladder.
Almost half of the study population reported experiencing
symptoms of SUI during the reference interval, but the prev-
alence of SUI was about 7% higher among women with UL
compared with women without UL after adjusting for age,
ethnicity, BMI, and number of deliveries. Relative to women
without UL, the prevalence of SUI was about 9% higher
among women with UL that were 2 cm and among women
with a very large uterine volume. However, large anterior UL,
which were hypothesized to be most likely to exert pressure on
the bladder, were not more strongly associated with SUI than
other UL; our estimates were imprecise, however, because few
women had such UL. Although fibroids were not as strongly
related to SUI as the established risk factors parity and high
BMI (aPDs of 13%–23%, data not shown), a 7%–9% increase in
prevalence is very important for this common condition.
To our knowledge, the association between the presence
of UL and SUI has been investigated in only one other
population-based epidemiological study. This community-
based study included 3302 women aged 42–52 years enrolled
in the Study of Women’s Health Across the Nation (SWAN)
cohort, a multiethnic longitudinal study of the natural history
of menopausal transition.17 The presence of UL was based on
self-reported diagnosis, and the presence of both stress and
Table 2. Estimated Prevalences and Crude and Adjusteda Percent Prevalence Differences
for Stress Urinary Incontinence among 836 Premenopausal Women, NIEHS Uterine Fibroid Study
Characteristic
Total SUI Crude Adjusted
n % n % PD (%) 95% CI PD (%) 95% CI
UL presence
No 302 36.1 140 46.4 0 0
Yes 534 63.9 274 51.3 5.0 2.1-12.0 7.4 0.4-14.3
UL size
No UL 302 36.1 140 46.4 0 0
<2 cm 143 17.1 68 47.6 1.2 8.7-11.1 2.1 7.5-11.7
2–4 cm 237 28.4 126 53.2 6.8 1.7-15.2 9.6 1.3-17.9
4 cm 154 18.4 80 52.0 5.6 4.1-15.2 9.3 0.4-18.9
Anterior ULb 4 cm
No UL 302 37.4 140 46.4 0 0
Yes 35 4.3 17 48.6 2.2 14.8-19.4 4.3 11.9-20.6
Other UL 470 58.2 241 51.3 4.9 2.3-12.1 7.4 0.2-14.4
Missing 29
Anterior ULb 2 cm
No UL 302 37.4 140 46.4 0 0
Yes 125 15.5 66 52.8 6.4 4.0-16.8 9.8 0.3-19.7
Other UL 380 47.1 192 50.5 4.2 3.4-11.7 6.2 1.3-13.7
Missing 29
Uterine sizec
Small 258 32.9 120 46.5 0 0
Medium 260 33.2 120 46.2 0.4 8.9-8.2 3.8 12.3-4.7
Large 132 16.8 66 50.0 3.5 7.0-13.9 1.1 9.7-11.8
Very large 134 17.1 76 56.7 10.2 0.2-20.4 8.7 1.9-19.0
Missing 52
aEstimated using linear risk models, adjusted for age at reference date, ethnicity, BMI, and number of deliveries.
bAnterior UL, UL located in the anterior wall of a nonretroverted uterus.
cSmall (91.4 cm3), medium (>91.4 cm3 and 148.9 cm3), large (>148.9 cm3 and 213.0 cm3), and very large (>213.0 cm3).
UL, uterine leiomyomata.
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urge urinary incontinence (at least monthly during the pre-
vious year) was assessed at baseline and the first five follow-
up visits. No association was found between self-reported UL
and prevalent SUI. The study found an association with
prevalent incontinence (stress, urge, or mixed combined) and
an association with prevalent urge incontinence (aOR¼ 1.53,
95% CI 1.08-2.27), especially among the African American
women (aOR¼ 1.95, 95% CI 1.07-3.54). No association was
found between self-reported UL and incident incontinence,
either overall or by specific subtype. It should be noted that
another study also reported no association between UL (as the
primary indication for hysterectomy) and self-reported SUI,21
but this was a highly selected sample, limited to women
having hysterectomies, and only an unadjusted OR was re-
ported.
There are also several studies that have evaluated the as-
sociation between hysterectomy and SUI symptoms. In a
prospective study, SUI prevalence dropped from 36% before
surgery to 19% 6 months after surgery.22 Two randomized
clinical trials also reported reductions in SUI after hyster-
ectomy.23,24 In the first clinical trial, the reduction in SUI
was associated with removal of uteri without UL as well as
uteri with UL, whereas in the second study, the SUI reduction
was attributed to the removal of uteri with large UL. We
found no literature on the effect of myomectomy or uterine
artery embolization on SUI, studies that would address
more directly the efficacy of removal of UL on the treatment
of SUI.
Strengths of our study include its sample size (474 African
American and 362 Caucasian women) and the sampling
method used to randomly select a sample of health plan
participants. Another strength is that the UL status was based
on ultrasound screening, therefore allowing women with
both symptomatic and asymptomatic UL to be accurately
classified with regard to UL status. The ultrasound data
also allowed us to characterize the size and location of
UL, characteristics not available from self-reported data. It
should be noted, however, that analyses of UL by location
were limited by the small number of women with large
anterior UL.
The study has also several limitations. Because the ultra-
sound was performed on average about 4 years before the
assessment of SUI symptoms and the development of new UL
and the growth of existing UL during the period are not ac-
counted for, our results may have underestimated the true
effect of UL presence and characteristics. Limitations regard-
ing the assessment of urinary incontinence symptoms in-
cluded the definition used, which asked only about urine
leakage when the women coughed or sneezed, without any
assessment of severity or the presence of urge urinary in-
continence. Another important study limitation was the ret-
rospective ascertainment of SUI during the 12-month interval
prior to the reference date, given that 21% of the women had
their reference date preceding the follow-up by 1 year and
15% of them had their reference date 2 years before the
follow-up. It is important to note, however, that excluding the
latter group caused only minor changes to the results. Re-
garding the severity, assuming a causal relationship, the effect
of UL would have been stronger if the outcome had been
restricted to more severe SUI symptoms. In addition, al-
though UL status was determined at baseline and SUI at
follow-up, the ages of onset of UL and SUI were unknown. It
is possible that the observed association between UL and SUI
was a consequence of shared causal factors.
In summary, we found an increase in SUI prevalence of
about 7% associated with the presence of UL, with slightly
larger increases in prevalence associated with larger UL.
These findings must be confirmed by other studies using a
more rigorous assessment of SUI before concluding that the
effective treatment of SUI may include treatment for large UL
in some cases.
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FIG. 1. Prevalence differences with 95% Cls for stress uri-
nary incontinence (SUI) associated with uterine leiomyomata
(UL) and UL characteristics (adjusted for age at reference
date, ethnicity, BMI, and number of deliveries) for 836 pre-
menopausal women, NIEHS Uterine Fibroid Study. Cut-off
points used to define the four categories of uterine size were
the 33rd percentile (91.4 cm3), the 66th percentile (148.9 cm3),
and the 83rd percentile (213 cm3) of the overall uterine vol-
ume distribution.
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